Recent Treatment Patterns of Oropharyngeal Cancer in Korea Based on the Expert Questionnaire Survey of the Korean Society for Head and Neck Oncology (KSHNO)
Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and...
Saved in:
Published in | Cancer Research and Treatment Vol. 53; no. 4; pp. 1004 - 1014 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Cancer Association
01.10.2021
대한암학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1598-2998 2005-9256 2005-9256 |
DOI | 10.4143/crt.2020.973 |
Cover
Abstract | Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea.Materials and Methods Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals.Results Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001).Conclusion In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future. |
---|---|
AbstractList | The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea.
Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals.
Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001).
In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future. Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea. Materials and Methods Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals. Results Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001). Conclusion In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future. KCI Citation Count: 0 Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea.Materials and Methods Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals.Results Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001).Conclusion In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future. The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea.PURPOSEThe incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A questionnaire survey was conducted to investigate the controversial treatment policy of stage T2 OPC according to the N category and determine the opinions of multidisciplinary experts in Korea.Five OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals.MATERIALS AND METHODSFive OPC scenarios were developed by the Subcommittee on Oropharyngeal Treatment Guidelines of the Korean Society for Head and Neck Oncology and distributed to experts of multidisciplinary treatment hospitals.Sixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001).RESULTSSixty-five experts from 45 institutions responded. For the HPV-positive T2N0M0 scenario, 67.7% of respondents selected surgery followed by definitive concurrent chemoradiotherapy (CCRT) or radiotherapy alone. For the T2N1M0 HPV-positive scenario, there was a notable difference in the selection of primary treatment by expert specialty; 53.9% of respondents selected surgery and 39.8% selected definitive CCRT as the primary treatment. For the T2N3M0 advanced HPV-positive scenario, 50.0% of respondents selected CCRT and 33.3% considered induction chemotherapy (IC) as the primary treatment. CCRT and IC were significantly more frequently selected for the HPV-related OPC cases (p=0.010). The interdepartmental variability showed that the head and neck surgeons and medical oncologists favored surgery, whereas the radiation oncologists preferably selected definitive CCRT (p < 0.001).In this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future.CONCLUSIONIn this study, surgery was preferred for lymph node-negative OPC, and as lymph node metastasis progressed, CCRT tended to be preferred, and IC was administered. Clinical practice patterns by stage and HPV status showed differences according to expert specialty. Multidisciplinary consensus guidelines will be essential in the future. |
Author | Woo Jin Jeong Jin Ho Song Yeon-Sil Kim Hyun Jun Hong Ji Hoon Kim Jeongshim Lee Young Hoon Joo Young Gyu Eun Hee Kyung Ahn Inn-Chul Nam Sung Ho Moon Kye Hye Choi Jin Ho Kim Sang Hoon Chun |
AuthorAffiliation | 2 Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 3 Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea 11 Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea 10 Department of Otolaryngology-Head and Neck Surgery, Kyung Hee University School of Medicine, Seoul, Korea 6 Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea 8 Department of Otorhinolaryngology-Head and Neck Surgery, International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea 7 Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea 9 Department of Otolaryngology-Head and Neck Surgery, Bucheon St. Mary’s Hospital, College of Medicine, The Ca |
AuthorAffiliation_xml | – name: 2 Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea – name: 9 Department of Otolaryngology-Head and Neck Surgery, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea – name: 7 Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea – name: 6 Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea – name: 1 Department of Radiation Oncology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea – name: 4 Department of Otolaryngology-Head and Neck Surgery, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea – name: 3 Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea – name: 12 Department of Radiation Oncology, Inha University Hospital, Inha University School of Medicine, Incheon, Korea – name: 10 Department of Otolaryngology-Head and Neck Surgery, Kyung Hee University School of Medicine, Seoul, Korea – name: 5 Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea – name: 8 Department of Otorhinolaryngology-Head and Neck Surgery, International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea – name: 11 Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea |
Author_xml | – sequence: 1 givenname: Kyu Hye surname: Choi fullname: Choi, Kyu Hye – sequence: 2 givenname: Jin Ho surname: Song fullname: Song, Jin Ho – sequence: 3 givenname: Yeon-Sil surname: Kim fullname: Kim, Yeon-Sil – sequence: 4 givenname: Ji-hoon surname: Kim fullname: Kim, Ji-hoon – sequence: 5 givenname: Woo-Jin surname: Jeong fullname: Jeong, Woo-Jin – sequence: 6 givenname: Inn-Chul surname: Nam fullname: Nam, Inn-Chul – sequence: 7 givenname: Jin Ho surname: Kim fullname: Kim, Jin Ho – sequence: 8 givenname: Hee Kyung surname: Ahn fullname: Ahn, Hee Kyung – sequence: 9 givenname: Sang Hoon surname: Chun fullname: Chun, Sang Hoon – sequence: 10 givenname: Hyun Jun surname: Hong fullname: Hong, Hyun Jun – sequence: 11 givenname: Young-Hoon surname: Joo fullname: Joo, Young-Hoon – sequence: 12 givenname: Young-Gyu surname: Eun fullname: Eun, Young-Gyu – sequence: 13 givenname: Sung Ho surname: Moon fullname: Moon, Sung Ho – sequence: 14 givenname: Jeongshim surname: Lee fullname: Lee, Jeongshim |
BackLink | https://cir.nii.ac.jp/crid/1872553967779608448$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/33540495$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002764927$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1Uk1v0zAYttAQ6wo3zsgHDptEipPYcXyZNKpBp00rrOVsOc6b1jS1i-NO9L_wY3HaDgESF7-W_Hy8evycoRPrLCD0OiUjmtL8vfZhlJGMjATPn6FBRghLRMaKEzRImSiTTIjyFJ113TdCCprz9AU6zXNGCRVsgH4-gAYb8NyDCuv-9lmFAN522DV46t1mqfzOLkC1eKysBo-NxbcuwvEH1UGNncVhCfj6xwZ8wF-20AXjrFXGA55t_SPseqUesmdZPHPaQNjhxnk8AVVjZWt8D3qFp1a71i12-Px2NrmfXrxEzxvVdvDqOIfo68fr-XiS3E0_3Yyv7hLN0jwkBdVFrSrORKZpzYWASqUUspJlVU5VURLBK8oZ4YKIuiCcFKypmqYRtKwqDfkQXRx0rW_kShvplNnPhZMrL68e5jdSlJyIaDdElwfsZlutoe7D86qVG2_WMag98-8Xa5ZR51HGbShJyyhwfhTw7nufllybTkPbKgtu28mMljxllNHe682fXr9Nnr4vArIDQHvXdR4aqU1Qff7R2rQyJbLviIwdkX1HZOxIJL37h_Sk-x_422M4xkT5_kxLnjGWi4JzLgpSUlrmvwD93sjs |
CitedBy_id | crossref_primary_10_1016_j_cllc_2022_02_001 crossref_primary_10_3857_roj_2021_00556 |
Cites_doi | 10.3857/roj.2017.00465 10.1016/s1470-2045(13)70011-1 10.1016/0167-8140(90)90162-p 10.1016/s1470-2045(10)70279-5 10.1002/14651858.cd010271.pub2 10.5037/jomr.2010.1301 10.3201/eid1611.100452 10.1200/jco.2011.36.4596 10.1093/annonc/mdt461 10.1016/j.prro.2017.02.002 10.1158/0008-5472.can-16-0633 10.1200/jco.2007.14.8841 10.1200/jco.2013.54.6309 10.1002/cncr.28595 10.1016/j.pvr.2018.12.002 10.1016/s1470-2045(15)00560-4 10.1056/nejmoa070956 10.1200/jco.2012.43.6097 10.1016/j.ijrobp.2019.08.038 10.1002/cncr.30508 10.1200/jco.2004.08.021 10.1093/annonc/mdu265 10.1016/j.ijrobp.2015.08.033 10.1200/jco.18.01921 10.1200/jco.2012.44.0164 |
ContentType | Journal Article |
Copyright | Copyright © 2021 by the Korean Cancer Association 2021 |
Copyright_xml | – notice: Copyright © 2021 by the Korean Cancer Association 2021 |
DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.4143/crt.2020.973 |
DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2005-9256 |
EndPage | 1014 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9870951 PMC8524018 33540495 10_4143_crt_2020_973 |
Genre | Journal Article Case Reports |
GeographicLocations | Republic of Korea |
GeographicLocations_xml | – name: Republic of Korea |
GrantInformation_xml | – fundername: Korean Society for Head and Neck Oncology |
GroupedDBID | --- 29B 5-W 53G 8JR 9ZL ABDBF ACUHS ACYCR ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL DIK E3Z EBD EF. F5P HYE OK1 RPM RYH TR2 AAYXX CITATION C1A CGR CUY CVF ECM EIF M~E NPM 7X8 5PM |
ID | FETCH-LOGICAL-c513t-64c6dab7592c4d799eba14e2852b34a68097b47507909d607065fbfff948bbce3 |
ISSN | 1598-2998 2005-9256 |
IngestDate | Sun Mar 09 07:51:09 EDT 2025 Thu Aug 21 14:08:45 EDT 2025 Fri Jul 11 09:24:35 EDT 2025 Thu Jan 02 22:54:58 EST 2025 Thu Apr 24 23:07:30 EDT 2025 Tue Jul 01 03:18:50 EDT 2025 Thu Jun 26 21:58:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Questionnaire study Human papillomavirus Oropharyngeal neoploasms Treatment patterns |
Language | English |
License | This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c513t-64c6dab7592c4d799eba14e2852b34a68097b47507909d607065fbfff948bbce3 |
Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ORCID | 0000-0002-4662-1916 0000-0002-5847-7317 0000-0002-7808-7877 0000-0002-7918-1072 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8524018 |
PMID | 33540495 |
PQID | 2487154541 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9870951 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8524018 proquest_miscellaneous_2487154541 pubmed_primary_33540495 crossref_citationtrail_10_4143_crt_2020_973 crossref_primary_10_4143_crt_2020_973 nii_cinii_1872553967779608448 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-10-01 |
PublicationDateYYYYMMDD | 2021-10-01 |
PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Cancer Research and Treatment |
PublicationTitleAlternate | Cancer Res Treat |
PublicationYear | 2021 |
Publisher | Korean Cancer Association 대한암학회 |
Publisher_xml | – name: Korean Cancer Association – name: 대한암학회 |
References | ref13 ref12 ref15 ref14 ref30 ref11 ref10 ref2 ref1 (ref25) 2020 ref16 ref19 Mehanna (ref18) 2019 Golusinski (ref21) 2019 ref24 ref23 ref26 ref20 ref22 Elrefaey (ref5) 2014 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 Gillison (ref17) 2019 |
References_xml | – ident: ref7 doi: 10.3857/roj.2017.00465 – start-page: 51 volume-title: Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial year: 2019 ident: ref18 – start-page: 388 volume-title: Current role of surgery in the management of oropharyngeal cancer year: 2019 ident: ref21 – ident: ref27 doi: 10.1016/s1470-2045(13)70011-1 – ident: ref22 doi: 10.1016/0167-8140(90)90162-p – ident: ref30 doi: 10.1016/s1470-2045(10)70279-5 – ident: ref13 doi: 10.1002/14651858.cd010271.pub2 – ident: ref24 doi: 10.5037/jomr.2010.1301 – ident: ref2 doi: 10.3201/eid1611.100452 – ident: ref3 doi: 10.1200/jco.2011.36.4596 – ident: ref28 doi: 10.1093/annonc/mdt461 – ident: ref9 doi: 10.1016/j.prro.2017.02.002 – ident: ref4 doi: 10.1158/0008-5472.can-16-0633 – ident: ref23 doi: 10.1200/jco.2007.14.8841 – year: 2020 ident: ref25 – ident: ref26 doi: 10.1200/jco.2013.54.6309 – ident: ref6 doi: 10.1002/cncr.28595 – ident: ref8 doi: 10.1016/j.pvr.2018.12.002 – ident: ref1 doi: 10.1016/s1470-2045(15)00560-4 – ident: ref29 doi: 10.1056/nejmoa070956 – start-page: 40 volume-title: Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial year: 2019 ident: ref17 – start-page: 299 volume-title: HPV in oropharyngeal cancer: the basics to know in clinical practice year: 2014 ident: ref5 – ident: ref16 doi: 10.1200/jco.2012.43.6097 – ident: ref20 doi: 10.1016/j.ijrobp.2019.08.038 – ident: ref15 doi: 10.1002/cncr.30508 – ident: ref14 doi: 10.1200/jco.2004.08.021 – ident: ref11 doi: 10.1093/annonc/mdu265 – ident: ref19 doi: 10.1016/j.ijrobp.2015.08.033 – ident: ref10 doi: 10.1200/jco.18.01921 – ident: ref12 doi: 10.1200/jco.2012.44.0164 |
SSID | ssj0064371 |
Score | 2.2444506 |
SecondaryResourceType | review_article |
Snippet | Purpose The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are... The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) has increased, and staging and optimal therapeutic approaches are challenging. A... |
SourceID | nrf pubmedcentral proquest pubmed crossref nii |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1004 |
SubjectTerms | Aged Carcinoma, Squamous Cell Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - therapy Carcinoma, Squamous Cell - virology Chemoradiotherapy Chemoradiotherapy - methods Combined Modality Therapy Female Follow-Up Studies Humans Male Middle Aged Original Oropharyngeal Neoplasms Oropharyngeal Neoplasms - pathology Oropharyngeal Neoplasms - therapy Oropharyngeal Neoplasms - virology Papillomaviridae Papillomaviridae - isolation & purification Papillomavirus Infections Papillomavirus Infections - complications Papillomavirus Infections - virology Practice Patterns, Physicians Practice Patterns, Physicians' - statistics & numerical data Prognosis Republic of Korea Robotic Surgical Procedures Robotic Surgical Procedures - methods Surveys and Questionnaires 의학일반 |
Title | Recent Treatment Patterns of Oropharyngeal Cancer in Korea Based on the Expert Questionnaire Survey of the Korean Society for Head and Neck Oncology (KSHNO) |
URI | https://cir.nii.ac.jp/crid/1872553967779608448 https://www.ncbi.nlm.nih.gov/pubmed/33540495 https://www.proquest.com/docview/2487154541 https://pubmed.ncbi.nlm.nih.gov/PMC8524018 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002764927 |
Volume | 53 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Cancer Research and Treatment, 2021, 53(4), , pp.1004-1014 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLV2kaa9IO4UGDIIJFCVLXGcix_XwVQ2sSFtk8ZTFDvOVg2cKbRI5bfwxh_l--wkbadOAl7cKnGcKOfE_mwfHxPyminuy1RLL0qT0uNBzjypAu6VChpDqZnyc6u2OIqHZ_zgPDpfWfk9p1qajOW2-rl0Xcn_oArHAFdcJfsPyHaFwgH4D_hCCghD-lcYQ8yHU_mnnVj8s3XLdMq247q6vszrqblA7-A9RBel5_3DCrL3B9B6Fc1MgfM7Hvft4Cc8rMmhHoQqpf6hp62GwF5lFkSeQ6CHnXs40uqqf2yUs3OCkPXwZHh03I4xzGwQ8AEacyG3nq5Tuc9EBpVTF0wn_eG049xJqxtGY65qJhuwXP6iK-OdzJQizeGDkTesGs41oxos6PRx0CjZ2s9apArmXMfbqtr5CjeU5HP1LvreLWsQOISDgKKqUTbL_G3h9k2Z48b1N0uOEMe_uNvv84YBd3tqlayzBAK0NbK-O3g_2G8bfJz6DNyaCrzdzvzNNslGe_lC4LNqRiNM63JZz-amQHcu4jm9S-40XRW663h3j6xoc59sfGrEGA_IL0c_2tGPtvSjVUkX6Ecd-nRkqCUStfSjlaHALeroRxfoRx39sCTM4uhHG_pRoB9F-lFgEUX60ZZ-9K0l37uH5Gz_w-ne0Gs2-_BUFIRjL-YqLnKZRAKqjyIRQss84JqlEZMhz-PUF4nkEN8mwhdF7OP0fCnLshQ8lVLp8BFZM5XRTwiNUqaLkoVaFYprWaRJoQAiFqpQqYiJHum3SGSqccLHDVm-ZtAjRggzgDBDCDOAsEfedLmvnQPMLfm2AFQoENMgTaCvHoo4SRIR-ynnaY-8ArizKzXK0NIdfy-q7KrOoOP6MRPQbkJnp0detmzIoJ7Hybvc6GryPWM8TbC7wyHPY8eO7nFaivVIssCbLgPecPGMGV1aL3l4vdwP0qe3lvmMbM6-z-dkbVxP9BbE4WP5ovkO_gDmFt4n |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+Treatment+Patterns+of+Oropharyngeal+Cancer+in+Korea+Based+on+the+Expert+Questionnaire+Survey+of+the+Korean+Society+for+Head+and+Neck+Oncology+%28KSHNO%29&rft.jtitle=Cancer+research+and+treatment&rft.au=Choi%2C+Kyu+Hye&rft.au=Song%2C+Jin+Ho&rft.au=Kim%2C+Yeon-Sil&rft.au=Kim%2C+Ji-Hoon&rft.date=2021-10-01&rft.eissn=2005-9256&rft.volume=53&rft.issue=4&rft.spage=1004&rft_id=info:doi/10.4143%2Fcrt.2020.973&rft_id=info%3Apmid%2F33540495&rft.externalDocID=33540495 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon |